SelectScience Editorial Article: Insights into the UK’s Largest Independent Integrated Drug Discovery CRO
SelectScience recently interviewed Denise Swift, a Senior Bioscientist, Project and Team Leader at Sygnature Discovery. Denise is responsible for evaluating new technologies to enhance Sygnature’s Bioscience capabilities – in particular, screening technologies, instrumentation and automation.
The interview highlighted Sygnature Discovery’s novel approach to custom assay development and revealed some of the secrets of our success in accelerating the discovery of new therapeutics.
The interview can be found here: http://www.selectscience.net/editorial-articles/insights-into-the-uks-largest-independent-integrated-drug-discovery-cro/?artID=43909
